Internet-based Videoconferencing to Address Alcohol Use and Pain
21. november 2019 opdateret af: Boston University Charles River Campus
Internet-based Video-conferencing to Address Alcohol Use and Pain Among Heavy Drinkers in HIV-care
This research seeks to develop a novel, integrated behavioral approach to reduce heavy drinking and chronic pain among patients in HIV-care delivered via internet-based videoconferencing.
This first open trial pilot study seeks to recruit patients in the clinic through posted flyers, cards and physician referral.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study seeks to develop an integrated, behavioral video telehealth approach to address pain and heavy alcohol use among patients living with HIV and determine its feasibility and acceptability.
Through an open pilot trial, this phase of this project will deliver an integrated alcohol-pain behavioral intervention to people living with HIV/AIDS (PLWHA) through videoconferencing.
Intervention evaluation outcomes for this initial phase will include reduction of standard number of drinks per week, reduction in heavy drinking days, reduction of chronic pain severity and interference, ratings of patient satisfaction with treatment, and rate of treatment adherence.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
8
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02215
- General Clinical Research Unit, Boston University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- engaged in HIV care, heavy drinking by more than 7/14 drinks per week (women/men) or by single episode of 4/5 (women/men), chronic (at least 3 months duration) moderate or greater (4 or more on the severity scale of the Brief Pain Inventory (BPI) non-cancer related pain.
Exclusion Criteria:
- psychoactive medication for pain or alcohol use for few than 2 months
- history of bipolar disorder, schizophrenia, other psychotic disorder
- current suicidal intent
- prior history of alcohol withdrawal related seizures or delirium tremens
- current behavioral treatment for pain or alcohol use
- any scheduled surgery within next 6 months or acute life-threatening illness that requires treatment
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention
participants all receive the intervention
|
Behavioral intervention that includes motivational, cognitive, and behavioral intervention strategies to reduce heavy drinking and chronic pain interference
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Brief Pain Inventory Pain Severity
Tidsramme: past 7 days
|
BPI consists of 11-point scale items that reflect pain severity and pain interference Average pain severity in the past 7-days is measures with a single 11-point scale where "0" is best and "10" is worst. Pain interference is measures as the mean of 7-items, each also rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10 |
past 7 days
|
|
Brief Pain Inventory Pain Interference
Tidsramme: past 7 days
|
BPI consists of 11-point scale items that reflect pain severity and pain interference Pain interference is measured as the mean of 7-items, each rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10 |
past 7 days
|
|
Alcohol Time Line Follow Back...Heavy Drinking Episodes
Tidsramme: past 30 days
|
number of heavy drinking episodes in the past 30 days
|
past 30 days
|
|
Alcohol Time Line Follow Back...Average Drinks Per Week
Tidsramme: past 30 days
|
average number of drinks per week in the past 30 days (total number of drinks 30 days/4.28)
|
past 30 days
|
|
Client Satisfaction Questionnaire-8 [Modified]
Tidsramme: past 30 days
|
Evaluative ratings of the intervention received. Eight Likert-scale items regarding different components of treatment satisfaction are rated from 1-4. Some items are reversed scored and then they are summed so that higher scores reflect higher satisfaction with treatment. The possible range of scores is 8-32. |
past 30 days
|
|
Perceptions of Treatment Questionnaire
Tidsramme: past 30 days
|
Participants were asked about their experiences with different facets of the intervention using items that were scored from 0 - 8 with higher scores reflecting greater satisfaction with the treatment components.
|
past 30 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Goal Systems Assessment Battery-Pain
Tidsramme: past 30 days
|
Ratings self-regulatory capacities related to pain.
Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items.
There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal.
A mean scale score is taken for each subscale.
The range for each subscale is 0-4.
Higher scores reflect better outcomes.
|
past 30 days
|
|
Goal Systems Assessment Battery-Alcohol
Tidsramme: past 30 days
|
Ratings self-regulatory capacities related to moderating alcohol use.
Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items.
There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal.
A mean scale score is taken for each subscale.
The range for each subscale is 0-4.
Higher scores reflect better outcomes.
|
past 30 days
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Tibor P Palfai, PhD, Boston University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. marts 2019
Primær færdiggørelse (Faktiske)
27. juni 2019
Studieafslutning (Faktiske)
27. juni 2019
Datoer for studieregistrering
Først indsendt
14. maj 2019
Først indsendt, der opfyldte QC-kriterier
10. juni 2019
Først opslået (Faktiske)
11. juni 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
13. december 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
21. november 2019
Sidst verificeret
1. november 2019
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 4546 (Anden identifikator: VA Portland Health Care System)
- UH2AA026192 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .